Milder Donald B's Form 4 filing
Inari Medical, Inc. (NARI) · filed Mar 18, 2022
- Accession no.
- 0001562180-22-002816
- Filed
- Mar 18, 2022
- Trade date
- Mar 3-16, 2022
- Filing delay
- 15 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $561.3K. It was filed 15 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Milder Donald BCIK 0001279660 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2022 | Common Stock | SSaleDisposed | −7,000 | $80.18F2 | −$561,260 | 237,203 | Direct | |
| Mar 3, 2022 | Common Stock | GGiftDisposed | −210,000 | $0.00 | $0 | 3,668,614 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $80.00 to $80.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.